Download PDF
1 / Pages

Other users also viewed these articles

Evaluation of in vitro activity of ceftolozane¿tazobactam against recent clinical bacterial isolates from Brazil ¿ the EM200 study Felipe Francisco Tuon; Juliette Cieslinski; Suellen da Silva Rodrigues; Fernando Brandão Serra; Marina Della-Negra de Paula;
Braz J Infect Dis. 2020;24:96-103
The impact of COVID-19 on microbiological profile and antibiotic consumption in ICU: a retrospective study in an infectious disease hospital in Brazil Verônica de França Diniz Rocha; Euclimeire Neves da Silva; Jailton Azevedo; Marcelo Teles Ribeiro; Mitermayer Galvão Reis; Tania Fraga Barros; Joice Neves Reis;
Braz J Infect Dis. 2024;28:
AVALIAÇÃO DA ATIVIDADE IN VITRO DE CEFIDEROCOL, CEFTAZIDIMA/AVIBACTAM E MEROPENEM/VABORBACTAM CONTRA BACTÉRIAS MULTIRRESISTENTES OBTIDAS DE PACIENTES INTERNADOS EM HOSPITAL TERCIÁRIO NO SUL DO BRASIL Patricia Orlandi Barth; Camila Mörschbächer Wilhelm; Aymê Duarte Echevarria; Kellen Figueira Tragnago; Richard Martins Carrassai; Afonso Luís Barth;
Braz J Infect Dis. 2023;27 Supl 1: